As of 2025-05-18, the Relative Valuation of Genomed SA (GEN.WA) is 20.45 PLN. This relative valuation is based on P/E multiples. With the latest stock price at 24.00 PLN, the upside of Genomed SA based on Relative Valuation is -14.8%.
The range of the Relative Valuation is 13.69 - 24.03 PLN.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 28.6x | 26.2x |
| Forward P/E multiples | 15.5x - 27.2x | 21.4x |
| Fair Price | 13.69 - 24.03 | 20.45 |
| Upside | -43.0% - 0.1% | -14.8% |
| Date | P/E |
| 2025-04-09 | 29.77 |
| 2025-04-08 | 29.77 |
| 2025-03-20 | 30.96 |
| 2025-03-17 | 30.01 |
| 2025-03-07 | 30.01 |
| 2025-02-24 | 29.77 |
| 2025-02-19 | 29.53 |
| 2025-02-18 | 33.35 |
| 2025-02-17 | 33.35 |
| 2025-02-13 | 33.35 |
| 2025-02-12 | 33.35 |
| 2025-02-11 | 33.35 |
| 2025-02-10 | 33.35 |
| 2025-02-07 | 33.35 |
| 2025-02-06 | 33.35 |
| 2025-02-05 | 33.11 |
| 2025-02-04 | 33.35 |
| 2025-02-03 | 32.87 |
| 2025-01-31 | 33.35 |
| 2025-01-30 | 33.35 |
| 2025-01-29 | 33.35 |
| 2025-01-28 | 33.35 |
| 2025-01-27 | 33.35 |
| 2025-01-23 | 33.35 |
| 2025-01-21 | 33.11 |
| 2025-01-20 | 33.58 |
| 2025-01-17 | 34.30 |
| 2025-01-16 | 34.54 |
| 2025-01-15 | 33.82 |
| 2025-01-14 | 32.15 |
| 2025-01-13 | 32.63 |